Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Alexander DJ . An overview of the epidemiology of avian influenza. Vaccine 2007; 25:5637–5644.
Skeik N, Jabr FI . Influenza viruses and the evolution of avian influenza virus H5N1. Int J Infect Dis 2008; 12:233–238.
Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. Nature 2005; 437:889–893.
Tumpey TM, Maines TR, Hoeven NV, et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 2007; 315:655–659.
Russell RJ, Haire LF, Stevens DJ, et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 2006; 443:45–49.
Mishin VP, Hayden FG, Gubareva LV . Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother 2005; 49:4515–4520.
Mitrasinovic PM . On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA). Biophys Chem 2009; 140:35–38.
Wade RC . 'Flu' and structure-based drug design. Structure 1997; 5:1139–1145.
Rameix-Welti MA, Enouf V, Cuvelier F, et al. Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog 2008; 4:e1000103.
Mihajlovic ML, Mitrasinovic PM . Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV). Biophys Chem 2008; 136:152–158.
Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol 1990; 215:403–410.
Collins PJ, Haire LF, Lin PY, et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008; 453:1258–1261.
Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 1998; 19:1639–1662.
Pearlman DA, Case DA, Caldwell JW, et al. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comp Phys Commun 1995; 91:1–41.
Chen LL, Gui CS, Luo X, et al. Cinanserin is an inhibitor of the 3C-Like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol 2005; 79:7095–7103.
Acknowledgements
This work was supported by grants from the State Key Program of Basic Research of China (2009CB918502), the Hi-Tech Research and Development Program of China (2006AA01A124), the MOST International Collaboration Program (2007DFB30370), the National Natural Science Foundation of China (20721003) and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant SIMM0709QN-09).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Yu, K., Luo, C., Qin, G. et al. Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)?. Cell Res 19, 1221–1224 (2009). https://doi.org/10.1038/cr.2009.111
Published:
Issue date:
DOI: https://doi.org/10.1038/cr.2009.111
This article is cited by
-
Comparative study of Danshen and Siwu decoction based on the molecular structures of the components and predicted targets
BMC Complementary Medicine and Therapies (2021)
-
Molecular modeling, docking and dynamics simulations of GNA-related lectins for potential prevention of influenza virus (H1N1)
Journal of Molecular Modeling (2012)
-
Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase
Journal of Molecular Modeling (2012)
-
Receptor recognition mechanism of human influenza A H1N1 (1918), avian influenza A H5N1 (2004), and pandemic H1N1 (2009) neuraminidase
Journal of Molecular Modeling (2012)
